Page last updated: 2024-10-29

iotrolan and Temporomandibular Joint Disorders

iotrolan has been researched along with Temporomandibular Joint Disorders in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischbach, R1
Heindel, W1
Lin, Y1
Friedrich, R1
Brochhagen, HG1

Other Studies

1 other study available for iotrolan and Temporomandibular Joint Disorders

ArticleYear
[A comparison of NMR tomography and arthrography in functional disorders of the temporomandibular joint].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 162, Issue:3

    Topics: Adolescent; Adult; Aged; Arthrography; Contrast Media; Evaluation Studies as Topic; Female; Humans;

1995